ATE69720T1 - Transdermales system fuer timolol. - Google Patents

Transdermales system fuer timolol.

Info

Publication number
ATE69720T1
ATE69720T1 AT85115940T AT85115940T ATE69720T1 AT E69720 T1 ATE69720 T1 AT E69720T1 AT 85115940 T AT85115940 T AT 85115940T AT 85115940 T AT85115940 T AT 85115940T AT E69720 T1 ATE69720 T1 AT E69720T1
Authority
AT
Austria
Prior art keywords
timolol
drug
transdermal system
irritation
accomplished
Prior art date
Application number
AT85115940T
Other languages
English (en)
Inventor
Joseph V Bondi
Alice E Loper
Edward M Cohen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE69720T1 publication Critical patent/ATE69720T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AT85115940T 1984-12-17 1985-12-13 Transdermales system fuer timolol. ATE69720T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/682,447 US4752478A (en) 1984-12-17 1984-12-17 Transdermal system for timolol
EP85115940A EP0186071B1 (de) 1984-12-17 1985-12-13 Transdermales System für Timolol

Publications (1)

Publication Number Publication Date
ATE69720T1 true ATE69720T1 (de) 1991-12-15

Family

ID=24739746

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85115940T ATE69720T1 (de) 1984-12-17 1985-12-13 Transdermales system fuer timolol.

Country Status (8)

Country Link
US (1) US4752478A (de)
EP (1) EP0186071B1 (de)
JP (1) JPH0684304B2 (de)
AT (1) ATE69720T1 (de)
CA (1) CA1261267A (de)
DE (1) DE3584766D1 (de)
DK (1) DK581685A (de)
ES (1) ES8702153A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797284A (en) * 1986-03-12 1989-01-10 Merck & Co., Inc. Transdermal drug delivery system
US4954343A (en) * 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
US4938759A (en) * 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US4956181A (en) * 1987-05-08 1990-09-11 Eastman Kodak Nitrate therapy for angina pectoris
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
JPH02149514A (ja) * 1988-04-06 1990-06-08 Nitto Denko Corp 医薬部材
FI82240C (fi) * 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.
US5508038A (en) * 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
US5484604A (en) * 1990-07-21 1996-01-16 Chatfield Pharmaceuticals Limited Cross-linked alginate transdermal medicine delivery devices
US5246706A (en) * 1991-07-19 1993-09-21 Cygnus Therapeutic Systems Device for administering bimakalim transdermally
ATE154513T1 (de) * 1992-07-08 1997-07-15 Leiras Oy Augenarzneimittel enthaltend timolol hemihydrat
DE4224325C1 (de) * 1992-07-23 1994-02-10 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster für niedrigschmelzende und/oder flüchtige Wirkstoffe und Verfahren zu seiner Herstellung
ES2199954T3 (es) * 1992-11-09 2004-03-01 Neurogesx, Inc. Administracion transdermica de cetorolac.
DE4400769C2 (de) * 1994-01-13 1996-07-18 Lohmann Therapie Syst Lts Verfahren und Vorrichtung zur Herstellung einer flächigen Darreichungsform mit einer Arzneimittelwirkstoffe enthaltenden Zubereitung
GB9711032D0 (en) * 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
EP1293210B1 (de) * 2001-05-23 2003-11-19 Pantarhei Bioscience B.V. Zubereitungen für die hormonale Kontrazeption
WO2002094277A1 (en) * 2001-05-23 2002-11-28 Pantarhei Bioscience B.V. Means and method for hormonal contraception
WO2002094280A1 (en) * 2001-05-23 2002-11-28 Pantarhei Bioscience B.V. Means and method for hormonal contraception
CN100581550C (zh) * 2001-12-05 2010-01-20 杜拉美德药物有限公司 预防怀孕和减少经期前症状的口服避孕药
WO2005007112A2 (en) * 2003-07-16 2005-01-27 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
EP1755618A1 (de) * 2004-05-26 2007-02-28 Wyeth a Corporation of the State of Delaware Zusammensetzungen und verfahren zur behandlung von prämenstrueller dysphorie
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
TW200726473A (en) * 2005-06-28 2007-07-16 Wyeth Corp Compositions and methods for treatment of cycle-related symptoms
US20090169606A1 (en) * 2005-12-08 2009-07-02 Fertin Pharma Low Flexural Strength Transdermal Tobacco Alkaloid Patch
FR2950802B1 (fr) 2009-10-02 2012-02-03 Sartorius Stedim Biotech Sa Elaboration et/ou conservation d'un produit biopharmaceutique.
DE102010002558A1 (de) 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
US9029415B2 (en) 2010-06-14 2015-05-12 Symrise Ag Cooling mixtures with an enhanced cooling effect of 5-methyl-2-(propane-2-yl)cyclohexyl-N-ethyloxamate
EP2394703B1 (de) 2010-06-14 2015-12-23 Symrise AG Kühlmischungen mit verstärkter Kühlwirkung von 5-Methyl-2-(propan-2-yl)cyclohexyl-N-ethyloxamat
WO2013041621A1 (de) 2011-09-20 2013-03-28 Basf Se Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung
KR102774558B1 (ko) 2015-12-30 2025-03-04 코리움, 엘엘씨 장기 경피 투여를 위한 시스템 및 방법
US11541018B2 (en) 2016-06-23 2023-01-03 Corium, Llc Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
EP3490544A1 (de) * 2016-07-27 2019-06-05 Corium International, Inc. Transdermale abgabesysteme für memantin
US11434220B2 (en) 2017-08-31 2022-09-06 Basf Se Use of physiological cooling active ingredients, and compositions comprising such active ingredients

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4060084A (en) * 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
JPS56133381A (en) * 1980-03-25 1981-10-19 Nippon Kayaku Co Ltd Pressure-sensitive adhesive tape or sheet containing nitroglycerin
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same
US4560553A (en) * 1981-07-07 1985-12-24 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US4440777A (en) * 1981-07-07 1984-04-03 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
JPS58134019A (ja) * 1982-02-05 1983-08-10 Ono Pharmaceut Co Ltd プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4474753A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
DE3319469A1 (de) * 1983-05-28 1984-11-29 Akzo Gmbh, 5600 Wuppertal System zur transdermalen applikation von pharmakotherapeutisch wirksamen substanzen
DE3586713T2 (de) * 1984-11-15 1993-05-13 Hercon Lab Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.

Also Published As

Publication number Publication date
JPH0684304B2 (ja) 1994-10-26
EP0186071B1 (de) 1991-11-27
DK581685D0 (da) 1985-12-16
CA1261267A (en) 1989-09-26
EP0186071A3 (en) 1988-09-14
EP0186071A2 (de) 1986-07-02
JPS61145113A (ja) 1986-07-02
US4752478A (en) 1988-06-21
DE3584766D1 (de) 1992-01-09
DK581685A (da) 1986-06-18
ES8702153A1 (es) 1987-01-01
ES550011A0 (es) 1987-01-01

Similar Documents

Publication Publication Date Title
ATE69720T1 (de) Transdermales system fuer timolol.
AU533491B2 (en) Bandage for administering drugs to the skin
ATE42901T1 (de) Haftendes arzneimittelpraeparat fuer perkutane absorption.
FI95539C (fi) Transdermaalinen järjestelmä, sen valmistusmenetelmä ja käyttö
MY100947A (en) External pharmaceutical composition.
CS9005598A2 (en) Method of transdermal therapeutic system's production with buprenorfin as active part
LTIP112A (en) The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
GR3003289T3 (en) Drug-containing plaster of the sustained-release type
NO163569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-thioxanthinderivater.
NZ509215A (en) Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels
EP0019403A3 (en) Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
MY105074A (en) Transdermal therapeutical system comprising norpseudoephedrine as active component.
GR3002566T3 (en) Dermal and transdermal therapeutic system having a discontinuous-pattern adhesive layer and method of manufacturing thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee